{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T23:31:54Z","timestamp":1789428714715,"version":"build-2803163510"},"reference-count":37,"publisher":"Wiley","license":[{"start":{"date-parts":[[2019,3,3]],"date-time":"2019-03-03T00:00:00Z","timestamp":1551571200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100009045","name":"Uniwersytet Jagiello\u0144ski Collegium Medicum","doi-asserted-by":"publisher","award":["K\/ZDS\/007717"],"award-info":[{"award-number":["K\/ZDS\/007717"]}],"id":[{"id":"10.13039\/100009045","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Disease Markers"],"published-print":{"date-parts":[[2019,3,3]]},"abstract":"<jats:p><jats:italic>Background<\/jats:italic>. Histidine-rich glycoprotein (HRG) displays anticoagulant and antifibrinolytic properties in animal models, but its effects in humans are unclear. We investigated serum HRG levels and their associations with the disease stage and prothrombotic alterations in lung cancer (LC) patients.<jats:italic>Methods<\/jats:italic>. In 148 patients with advanced LC prior to anticancer therapy (87 non-small-cell LC and 61 small-cell LC) versus 100 well-matched controls, we measured HRG levels in association with clot permeability (<mml:math xmlns:mml=\"http:\/\/www.w3.org\/1998\/Math\/MathML\" id=\"M1\"><mml:msub><mml:mrow><mml:mi>K<\/mml:mi><\/mml:mrow><mml:mrow><mml:mtext>s<\/mml:mtext><\/mml:mrow><\/mml:msub><\/mml:math>), clot turbidimetry (lag phase and maximum absorbance), and clot lysis time (CLT).<jats:italic>Results<\/jats:italic>. Compared to controls, LC patients had 45.9% lower HRG levels with no associations with demographics and comorbidities. Decreased HRG, defined as the 90<jats:sup>th<\/jats:sup>percentile of control values (&lt;52.7\u2009<jats:italic>\u03bc<\/jats:italic>g\/ml), was 16 times more common in subjects with than without LC (<mml:math xmlns:mml=\"http:\/\/www.w3.org\/1998\/Math\/MathML\" id=\"M2\"><mml:mtext>OR<\/mml:mtext><mml:mo>=<\/mml:mo><mml:mn>16.4<\/mml:mn><\/mml:math>, 95% CI 9.2-23.5,<mml:math xmlns:mml=\"http:\/\/www.w3.org\/1998\/Math\/MathML\" id=\"M3\"><mml:mi>p<\/mml:mi><mml:mo>&lt;<\/mml:mo><mml:mn>0.01<\/mml:mn><\/mml:math>).<mml:math xmlns:mml=\"http:\/\/www.w3.org\/1998\/Math\/MathML\" id=\"M4\"><mml:mtext>HRG<\/mml:mtext><mml:mo>&lt;<\/mml:mo><mml:mn>38<\/mml:mn><\/mml:math>\u2009<jats:italic>\u03bc<\/jats:italic>g\/ml discriminated stage IIIAB\/limited disease from IV\/extensive disease (ED) LC. In LC patients, HRG correlated inversely with CLT (<mml:math xmlns:mml=\"http:\/\/www.w3.org\/1998\/Math\/MathML\" id=\"M5\"><mml:mi>r<\/mml:mi><mml:mrow><mml:mo>=<\/mml:mo><\/mml:mrow><mml:mrow><mml:mo>\u2212<\/mml:mo><\/mml:mrow><mml:mn>0.41<\/mml:mn><\/mml:math>,<mml:math xmlns:mml=\"http:\/\/www.w3.org\/1998\/Math\/MathML\" id=\"M6\"><mml:mi>p<\/mml:mi><mml:mo>&lt;<\/mml:mo><mml:mn>0.001<\/mml:mn><\/mml:math>), but not with other fibrin variables. Among stage IV\/ED LC, HRG correlated significantly with<mml:math xmlns:mml=\"http:\/\/www.w3.org\/1998\/Math\/MathML\" id=\"M7\"><mml:msub><mml:mrow><mml:mi>K<\/mml:mi><\/mml:mrow><mml:mrow><mml:mtext>s<\/mml:mtext><\/mml:mrow><\/mml:msub><\/mml:math>and lag phase (<mml:math xmlns:mml=\"http:\/\/www.w3.org\/1998\/Math\/MathML\" id=\"M8\"><mml:mi>r<\/mml:mi><mml:mo>=<\/mml:mo><mml:mn>0.28<\/mml:mn><\/mml:math>and<mml:math xmlns:mml=\"http:\/\/www.w3.org\/1998\/Math\/MathML\" id=\"M9\"><mml:mi>r<\/mml:mi><mml:mo>=<\/mml:mo><mml:mn>0.33<\/mml:mn><\/mml:math>, respectively, both<mml:math xmlns:mml=\"http:\/\/www.w3.org\/1998\/Math\/MathML\" id=\"M10\"><mml:mi>p<\/mml:mi><mml:mo>&lt;<\/mml:mo><mml:mn>0.001<\/mml:mn><\/mml:math>). LC patients with low<mml:math xmlns:mml=\"http:\/\/www.w3.org\/1998\/Math\/MathML\" id=\"M11\"><mml:msub><mml:mrow><mml:mi>K<\/mml:mi><\/mml:mrow><mml:mrow><mml:mtext>s<\/mml:mtext><\/mml:mrow><\/mml:msub><\/mml:math>(10<jats:sup>th<\/jats:sup>percentile of control values) combined with prolonged CLT (90<jats:sup>th<\/jats:sup>percentile of control values) had reduced HRG levels compared to the remainder (<mml:math xmlns:mml=\"http:\/\/www.w3.org\/1998\/Math\/MathML\" id=\"M12\"><mml:mi>p<\/mml:mi><mml:mo>=<\/mml:mo><mml:mn>0.003<\/mml:mn><\/mml:math>). No such observations were noted in controls.<jats:italic>Conclusions<\/jats:italic>. Our study is the first to show that decreased HRG levels occur in advanced LC and are associated with the disease stage and hypofibrinolysis.<\/jats:p>","DOI":"10.1155\/2019\/8170759","type":"journal-article","created":{"date-parts":[[2019,3,3]],"date-time":"2019-03-03T23:35:18Z","timestamp":1551656118000},"page":"1-7","source":"Crossref","is-referenced-by-count":23,"title":["Decreased Levels of Histidine-Rich Glycoprotein in Advanced Lung Cancer: Association with Prothrombotic Alterations"],"prefix":"10.1155","volume":"2019","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5819-8414","authenticated-orcid":true,"given":"Aleksandra","family":"Winiarska","sequence":"first","affiliation":[{"name":"Institute of Cardiology, Jagiellonian University Medical College, Pradnicka 80, 31-202 Cracow, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lech","family":"Zareba","sequence":"additional","affiliation":[{"name":"Faculty of Mathematics and Natural Sciences, University of Rzeszow, Rejtana 16C, 35-959 Rzeszow, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grzegorz","family":"Krolczyk","sequence":"additional","affiliation":[{"name":"Oncology Ward, John Paul II Hospital, Pradnicka 80, 31-202 Cracow, Poland"},{"name":"Faculty of Medicine and Health Sciences, Andrzej Frycz Modrzewski Krakow University, Herlinga-Grudzinskiego 1, 30-705 Cracow, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grzegorz","family":"Czyzewicz","sequence":"additional","affiliation":[{"name":"Oncology Ward, John Paul II Hospital, Pradnicka 80, 31-202 Cracow, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1762-308X","authenticated-orcid":true,"given":"Michal","family":"Zabczyk","sequence":"additional","affiliation":[{"name":"Institute of Cardiology, Jagiellonian University Medical College, Pradnicka 80, 31-202 Cracow, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3716-1724","authenticated-orcid":true,"given":"Anetta","family":"Undas","sequence":"additional","affiliation":[{"name":"Institute of Cardiology, Jagiellonian University Medical College, Pradnicka 80, 31-202 Cracow, Poland"},{"name":"Center for Research and Medical Technology, John Paul II Hospital, Pradnicka 80, 31-202 Cracow, Poland"},{"name":"Faculty of Medicine and Health Sciences, Jan Kochanowski University, IX Wiekow Kielc 19A, 25-317 Kielce, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","reference":[{"key":"1","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.200504-531OE"},{"key":"2","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.29210"},{"key":"3","doi-asserted-by":"publisher","DOI":"10.1016\/j.soc.2016.02.001"},{"key":"4","first-page":"56","volume":"4","year":"2013","journal-title":"Hematologia"},{"key":"5","doi-asserted-by":"publisher","DOI":"10.1111\/j.1538-7836.2008.02908.x"},{"key":"6","doi-asserted-by":"publisher","DOI":"10.1186\/s40248-015-0021-4"},{"key":"7","doi-asserted-by":"publisher","DOI":"10.1161\/ATVBAHA.111.230631"},{"key":"8","doi-asserted-by":"publisher","DOI":"10.1160\/TH14-01-0032"},{"key":"9","doi-asserted-by":"publisher","DOI":"10.1016\/j.thromres.2010.07.021"},{"key":"10","doi-asserted-by":"publisher","DOI":"10.3322\/canjclin.48.3.167"},{"key":"11","doi-asserted-by":"publisher","DOI":"10.1016\/j.thromres.2012.11.033"},{"key":"12","doi-asserted-by":"publisher","DOI":"10.1111\/eci.12269"},{"key":"13","doi-asserted-by":"publisher","DOI":"10.1160\/TH15-04-0357"},{"key":"14","doi-asserted-by":"publisher","DOI":"10.1515\/bchm2.1972.353.2.1841"},{"key":"15","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2010-09-303842"},{"key":"16","doi-asserted-by":"publisher","DOI":"10.1016\/0885-4505(86)90127-1"},{"key":"17","doi-asserted-by":"publisher","DOI":"10.1021\/pr300330z"},{"key":"18","doi-asserted-by":"publisher","DOI":"10.4149\/neo_2014_001"},{"issue":"2","key":"19","first-page":"593","volume":"34","year":"2014","journal-title":"Anticancer Research"},{"key":"20","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-1711.2005.01320.x"},{"key":"21","doi-asserted-by":"publisher","DOI":"10.1111\/j.1538-7836.2005.01238.x"},{"key":"22","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0040033"},{"key":"23","doi-asserted-by":"publisher","DOI":"10.2353\/ajpath.2010.090782"},{"key":"24","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-11-2194"},{"key":"25","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccr.2010.11.009"},{"key":"26","doi-asserted-by":"publisher","DOI":"10.1007\/s12032-014-0897-4"},{"key":"27","doi-asserted-by":"publisher","DOI":"10.1186\/1756-8722-4-15"},{"key":"28","doi-asserted-by":"publisher","DOI":"10.4236\/ojbd.2017.71002"},{"key":"29","doi-asserted-by":"publisher","DOI":"10.21037\/jtd.2018.11.19"},{"key":"30","doi-asserted-by":"publisher","DOI":"10.1111\/cea.12734"},{"key":"31","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2009-05-222380"},{"key":"32","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2004-08-3253"},{"key":"33","doi-asserted-by":"publisher","DOI":"10.20452\/pamw.4165"},{"issue":"6","key":"34","doi-asserted-by":"crossref","first-page":"3803","DOI":"10.1016\/S0021-9258(18)32737-6","volume":"258","year":"1983","journal-title":"The Journal of Biological Chemistry"},{"key":"35","doi-asserted-by":"publisher","DOI":"10.1172\/JCI112435"},{"key":"36","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-35034-x"},{"key":"37","doi-asserted-by":"publisher","DOI":"10.20452\/pamw.4297"}],"container-title":["Disease Markers"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/downloads.hindawi.com\/journals\/dm\/2019\/8170759.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/downloads.hindawi.com\/journals\/dm\/2019\/8170759.xml","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/downloads.hindawi.com\/journals\/dm\/2019\/8170759.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,14]],"date-time":"2023-09-14T03:57:30Z","timestamp":1694663850000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.hindawi.com\/journals\/dm\/2019\/8170759\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3,3]]},"references-count":37,"alternative-id":["8170759","8170759"],"URL":"https:\/\/doi.org\/10.1155\/2019\/8170759","relation":{},"ISSN":["0278-0240","1875-8630"],"issn-type":[{"value":"0278-0240","type":"print"},{"value":"1875-8630","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,3,3]]}}}